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Candidate gene effects consistently fail to replicate. However, because it is now known that most 
genetic effects are incredibly minute, samples of the size typically employed in psychological 
research were undoubtedly too small to detect the effects of individual candidate genes. In 
addition, research showing strong genetic correlation among mental disorders suggests data on 
multiple disorders and their symptoms is the most appropriate for uncovering the etiology of 
mental illness. That is, single gene, single disorder studies are underpowered. We tested whether 
the combined effect of 121 candidate genes was sufficient to predict psychopathology in a 
sample of 343 adolescents. A genetic risk score was created with highly precise effect estimates 
from a genome-wide association study (GWAS) on 337,199 people. To maximize the strength of 
this score, we used transdiagnostic p-factor model scores as our measure of psychopathology. 
The genetic risk scores failed to predict in our sample and were dwarfed by age and gender 
effects, mirroring the genes’ weak and mostly non-significant results in the GWAS. Our results 
are most consistent with the view that the candidate gene approach is obsolete. However, modern 
molecular genetics studies like GWAS currently lack detailed, thorough phenotype 
measurement. Future work should focus on developing high quality, deeply phenotyped data 
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CHAPTER 1: INTRODUCTION 
Due to its prevalence and persistent nature, mental illness is estimated to have the greatest 
disability burden of all diseases types worldwide, with major depressive disorder (MDD) 
individually ranking #5 out of 291 conditions included in the Global Burden of Disease Study 
(Murray et al., 2013). In any given year, 1 in 5 people meet criteria for diagnosis of a mental 
disorder (Steel et al., 2014). Given the substantial cost to society mental illness imposes, 
increasing public interest surrounds the issue. In 2013, then-president Obama launched the Brain 
Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative and hosted a 
National Conference on Mental Health. Still, successful treatment of psychopathology lags, and 
diagnosis remains thoroughly descriptivist. In an effort to steer research toward biological 
mechanisms, the National Institute of Mental Health (NIMH) implemented the Research and 
Domain Criteria (RDoC). 
A component of RDoc concerns how genes influence psychology and behavior. Behavior 
genetics traditionally incorporates twin and family studies and, more recently, molecular genetic 
studies. Both approaches can estimate the degree to which traits are influenced by genes: twin 
studies by comparing the similarity of identical twins to that of fraternal twins and molecular 
genetic studies by correlating specific mutations with traits. In terms of mental disorders, this 
generally means examining rates of psychopathological morbidity in twin pairs and comparing 
the genotypes of clinical patients with those of unaffected individuals. If identical twins are 
diagnosed with the same disorder more often than fraternal twins are, we have evidence of 
genetic influence. If some mutations are more common in patients of that disorder, we have 
evidence that those mutations are in part responsible for that genetic influence.   
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According to twin studies, approximately 50% of the variation in all measured human traits, and 
46% of the variation in all psychiatric traits, can be attributed to genetics (Polderman et al., 
2015). Molecular genetics generally provides lower estimates, purportedly due to current 
limitations in the technology and inadequate sample sizes (Yang et al., 2015). Molecular genetic 
estimates have increased with time, the development of new methodologies, and sample size 
(Speed et al., 2017). 
Sample size is a key issue in the history of molecular behavior genetics. Another key 
issue is the complex, correlated architecture of psychopathology. As would be expected with a 
predominance of comorbidity, genetic correlation among psychiatric illnesses abounds. 
Molecular genetic estimates place the genetic correlation between Bipolar I (BP1) and 
Schizophrenia (SCZ) at r = .68. Even MDD, which does not have a history of being 
phenotypically associated with SCZ, exhibits a moderate genetic correlation with it at r = .43 
(Lee et al., 2013). Specifying traits that are closest to biological reality is the first step to 
uncovering genetic influences on psychopathology. 
The Structure of Psychopathology 
Correlated dimensions, not categories. 
It has become increasingly apparent to researchers and clinicians alike that the complex 
structure of mental illness is not well captured by a categorical diagnostic system like that of the 
DSM, and that it would be bettered served by continuous dimensions. Mental disorders are 
simultaneously too narrow and too broad in scope, with rampant comorbidity and symptom 
heterogeneity the norm rather than the exception.  
The prototypical example of disorder comorbidity is depression and anxiety. Around 60% 
of depressed participants in a US representative epidemiological study of mental health had at 
least one comorbid anxiety disorder (Kessler, Chiu, Demler, Merikangas, & Walters, 2005). The 
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murkiness of the boundary between depression and anxiety is even more apparent at the 
symptom level. Over 95% of depressed patients experience at least one anxiety symptom, and up 
to 65% of anxious patients experience low mood (Hranov, 2007).  
 As for the contrasting issue of symptom heterogeneity, schizophrenia has long been 
recognized as being comprised of several disparate symptoms that may not be shared even 
among several patients. There have been several attempts to create subtypes of schizophrenia 
based on the nature, severity, and onset of the symptoms such as the distinction between the 
paranoid, catatonic, and disorganized. Apart from the division between negative and positive 
symptoms, such subtyping approaches have fallen out of favor, but the issue of symptom 
heterogeneity remains (Keller, Fischer, & Carpenter, 2011). 
 Another consequence of the current arrangement is the paradoxical pairing of diagnostic 
instability with symptom stability. Patients often drift from diagnosis to diagnosis while by and 
large experiencing the same symptoms and responding similarly to identical treatments (Kotov et 
al., 2017). In addition, due to the arbitrary thresholds for diagnosis and without a formal 
dimension of severity, subclinical presentations are ignored and severe cases are not adequately 
tagged. This is in opposition to other areas of medicine, which fluidly combine severity 
dimensions with categorical diagnoses (Carragher, Krueger, Eaton, & Slade, 2015). Arranging 
symptoms on dimensions ameliorates these shortcomings and clarifies the relationships between 
disorders and between symptoms. 
The structure of psychopathology is hierarchical. 
Evidence has converged around hierarchical structures of psychopathology that account 
not only for the comorbidity of closely-linked disorders but also among all forms of 
psychopathology. Though some models retain DSM categories by using latent class analysis or 
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some hybrid categorical/dimensional modelling, continuous, symptom-based measures 
predominate and offer the strongest level of prediction. (Kotov et al., 2017). Through 
covariance-based methods – principally, factor analysis – clusters of correlated symptoms can be 
organized into overarching dimensions. In these frameworks, disorders are understood as 
specific combinations of symptoms and/or as profiles with varying scores on the dimensions.  
 The latest of these hierarchical models is the Hierarchical Taxonomy of Psychopathology 
(HiTOP; Kotov et al., 2017) which expands Caspi and colleagues’ (2014) P-factor model. The P-
factor model and HiTOP go beyond the widely accepted and successful 
internalizing/externalizing dichotomy by establishing “superspectra” that refer to a general 
liability for mental illness. Just as there is a “g factor” for general intelligence, there is a “p 
factor” for psychopathology, argued Caspi and colleagues (2014).  
 Below this all-encompassing psychopathology superspectrum exist narrower spectra: 
internalizing, externalizing, and thought disorder (Figure 1).  Internalizing refers to a tendency to 
direct negative feelings and behaviors toward the self. Disorders that could be classified as 
internalizing or which have substantial internalizing components include: MDD, Generalized 
Anxiety Disorder (GAD), Obsessive Compulsive Disorder (OCD), Post-traumatic Stress 
Disorder PTSD, and Anorexia Nervosa (AN). Externalizing, on the other hand, refers to a 
tendency to direct the negativity outward. Disorders that could be classified as externalizing or 
which have substantial externalizing components include: Attention Deficit Hyperactivity 
Disorder (ADHD), the Substance Use Disorders (SUDs), Oppositional Defiant Disorder (ODD), 
Conduct Disorder (CD), Antisocial Personality Disorder (ASPD), and Intermittent Explosive 
Disorder (IED). The thought disorder spectrum, comprised of psychotic symptoms experienced 
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in schizophrenia and related disorders, is also well-replicated (Kotov et al., 2017) but does not 
emerge as clearly in adolescent samples due to the later age of onset for psychotic disorders.  
 
Figure 1 The P-factor Model in HiTOP terminology. For simplicity, symptomology spread 
across spectra, such as BP1’s manic psychosis, are not pictured.  
 
Though DSM disorders are abandoned in HiTOP, they can be interpreted in the same 
way as they are in other hierarchical models - as combinations of different symptoms across the 
spectra (Figure 1). Some disorders fit more neatly within a single spectrum than others. The most 
characteristic symptoms of MDD, for example, spread across multiple subfactors of internalizing 
such as distress and negative affectivity, but they all fall within internalizing. Bipolar I, in 
contrast, has both substantial affective and thought disorder components due in part to manic 
psychosis. 
The meaning of the P-factor and superspectra. 
HiTOP, P-factor, and other hierarchical models describe and predict psychopathology 















superspectra actually mean etiologically is an area of ongoing research. The authors of HiTOP 
attest that the spectra and superspectra are meaningful units of analysis that are more useful than 
DSM diagnoses for understanding genetic contributions to psychopathology (Kotov et al., 2017). 
However, there are three alternative explanations that fit the data to varying degrees.  
 The most conservative explanation dismisses the spectra as being artifactual, perhaps due 
to common method bias or symptom mislabeling. For example, attention problems in a child 
may be mistaken for intellectual disability or a patient may over-lump their symptoms together 
because they misinterpret survey questions. In both cases, artificial correlations between 
symptoms and disorders would be observed. This argument is contradicted by agreement 
between studies that use various designs, measurements, and samples (Kotov et al., 2017). 
Notably, clinician ratings of their patients’ symptoms also reproduce the P-factor structure, even 
though they are trained in the DSM (Morey, Krueger, & Skodol, 2013). 
 A related line of argument disputes the interpretation of the statistics: principally, that 
correlational studies cannot demonstrate causality, and, therefore, that factors are better 
understood as summaries, not causes, of their subfactors. Caspi and colleagues (2014) 
themselves asked in their paper, “Is p merely a statistical reductio ad absurdum or is it real and 
meaningful?” (p. 132). Wood, Gardner, and Harms (2015) discussed the limitations of 
covariance-based methods used in non-experimental, cross-sectional studies. Longitudinal and 
twin designs get closer to causality, but an additional problem remains: superordinate factors are 
always estimated more accurately than their components. For personality inventories, facets by 
definition have fewer items than the factors they comprise; for psychopathology, a grouping of 
disorders necessarily contains more cases than any one disorder.  Modeled effects will be most 
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strongly tied to factors. Even if the causal direction is in fact reversed, the subfactors will look 
like noise.  
 The most popular argument against shared genetic etiology is the causal or temporal 
hypothesis that related disorders cause one another. For instance, anxiety and depression can 
appear to occur cyclically (Hranov, 2007). This hypothesis has not been ruled out as of yet, 
necessitating more longitudinal studies. Some have found that disorders are more fine grained in 
adolescence and that comorbidity increases with age, the opposite of what would be expected 
with a general, transdiagnostic cause (Hranov, 2007). Even with the g factor for general 
intelligence, debate persists around whether it should be understood as a cause or as a 
consequence of events during development. 
 Finally, the genetic etiology perspective serves as the basis for this study and most 
behavior genetics investigations of psychopathology. Though behavior genetics is not 
incompatible with the developmental hypothesis, it is increasingly assumed that genes primarily 
contribute to psychopathology generally (or transdiagnostically) rather than specifically for any 
one disorder. That is, genetic effects are expected to have the greatest prevalence and strength at 
the spectra and superspectra levels – e.g. with the p-factor and/or internalizing instead of MDD. 
Twin and family studies have borne this out for over a decade. For example, when multiple 
externalizing disorders are analyzed together in a twin study design, the estimated proportion of 
externalizing behavior variance due to genetics (i.e. heritability) is maximized at the level of the 
entire externalizing spectrum – specifically up to 84% (Young, Stallings, Corley, Krauter, & 
Hewitt, 2000), which is up to 50 percentage points higher than estimates for individual disorders 
(Hicks, Krueger, Iacono, McGue, & Patrick, 2004).  
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 With such powerful genetic effects on psychopathology, one might expect that the 
genetic architecture involved would be fairly simple once comorbidity is handled as a given with 
a small set of easily identifiable genes responsible. That scenario, while attractive, is far removed 
from the truth. The genotypic structure of psychopathology is infinitely more complex than the 
already complicated phenotypic structure, with many more moving pieces that demand of 
researchers ever greater care with measurement and sampling. 
The Traditional Candidate Gene Approach 
Before modern sequencing technology, focusing on individual genes like 5-HTTLPR-S 
and MAOA-L was a necessity, as genotyping more than a handful of genetic variants was time 
intensive and cost-prohibitive. “Candidate genes” with the strongest theoretical support were 
included.  Though genotyping many millions more genetic variants is comparatively less 
expensive and time consuming today, candidate genes studies are still attractive to many because 
they presumably allow for a closer interrogation of biological mechanism than would be feasible 
in large, atheoretical approaches like genome-wide association studies (GWASs) in which 
mutations at millions of individual points along the As,Ts,Cs and Gs of the genetic code are 
correlated with a trait (as described in-depth below). Unsurprisingly, just how reasonable it is to 
sift through so many single nucleotide polymorphisms (SNPs) is questioned.  
 Unfortunately, the candidate gene approach has fallen out of favor due to rampant 
replication failures and unreliable effect size estimates in the literature. Many researchers suspect 
the same methodological problems plaguing other areas of psychological science - namely, the 
file drawer effect, selective reporting of data, and low statistical power (Dick et al., 2015; 
Duncan & Keller, 2011; Duncan, 2014). Negative results appear to have been suppressed, and 
small sample size studies were vulnerable to false positives and poor effect estimates. For 
example, (Duncan & Keller, 2011) meta-analyzed the candidate-gene-by-environment literature 
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and found that effect sizes were negatively correlated with sample size and time of publication. 
In other words, the landmark studies first establishing the GxE effect used small samples and 
later studies with larger samples failed to replicate. They also found that GxE reports often used 
misspecified interaction models, such that an unknown proportion of apparent GxE effects may 
be better explained by interactions between covariates and environmental conditions – no gene 
effects necessary. 
 The widespread suspicion surrounding candidate genes is supported by a recent failed 
replication attempt on the main effects of popular candidate genes on SUDs and externalizing 
disorders (Samek et al., 2016). By virtue of its 3,487-person sample size, this study had a 97% 
chance of detecting effects that are but a fraction of the size estimated by candidate gene meta-
analyses – yet not one candidate gene replicated. In other words, Samek and colleagues (2016) 
had a near-certainty of detecting the effects claimed by the literature, and they did not find any. 
 Rare variants can theoretically surpass the minute effects of common mutations/alleles 
(Gibson, 2012). Natural selection keeps them at a low frequency in the population because they 
are deleterious - e.g. the mutations that cause achondroplasia dwarfism, G1138A and G1138C 
polymorphisms of fibroblast growth factor receptor 3 (FGFR3) gene. However, classic candidate 
genes are neither rare nor technically “genes” at all. They are instead common alleles found in a 
large proportion of the healthy population. Candidate gene selection was inspired by research in 
which gene function was tremendously compromised or altered, including “gene knockout” 
experiments or rare genetic disorders such as Brunner’s Syndrome (Brunner et al., 1993). 
Despite this, only one common polymorphism of many in a gene would be selected to represent 
the entire gene, and they were necessarily common variants to make finding participants feasible. 
The MAOA-L, 5-HTTLPR-S, DRD4-L, and DRD2 Taq1A risk alleles are variants readily found in 
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large portions of the population. The most common MAOA-L polymorphism is carried by 30% of 
Caucasian men (Raine, 2014).  Candidate genes would be more accurately dubbed “candidate 
alleles”, and the effects of common alleles are small. 
The Infinitesimal Model and GWAS 
If candidate gene effects do exist, they are almost certainly much smaller and require 
larger sample sizes. In 1919, R.A Fisher demonstrated mathematically that normally distributed 
traits could not possibly arise from mendelian patterns of inheritance but instead from the 
combined, infinitesimally small effects of many genetic variants (Fisher, 1919). Dubbed the 
“infinitesimal model”, this insight by Fisher has been confirmed by GWASs. In a GWAS of over 
250,000 people, 697 single nucleotide polymorphisms (SNPs) identified as significantly 
associated with human height together accounted for only 20% of the variability in height 
attributable to genes (Yang et al., 2010). Psychological and behavioral traits show even greater 
polygenicity (Okbay et al., 2016), so much so that polygenicity has been dubbed a “law” of 
behavior genetics (Chabris, Lee, Cesarini, Benjamin, & Laibson, 2015). With so many genes 
working together in concert, GWAS is in fact better equipped for uncovering biological 
mechanisms than candidate gene studies are. 
 GWASs simultaneously analyze millions of genetic variants, specifically SNPs, in a 
single study. If the DNA double helix can be thought of as a ladder when unwound and laid flat, 
the individual rungs on that ladder are single nucleotides. One way that this ladder can differ 
between individuals is by a change at the level of one individual rung. Where one person may 
have adenine (A) at a particular rung, another may have guanine (G) in the same place. Because 
it is one rung, it is a single nucleotide and, because it varies among members of a population, it is 
a polymorphism (having “multiple forms”). These are the polymorphisms investigated in a 
GWAS, SNPs. The most common design in psychiatric GWASs is case control, which examine 
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the frequency of SNP alleles in cases relative to controls through logistic regression. Alleles that 
have an odds ratio greater than 1 for being a case are tagged as risk alleles. GWASs on 
psychological traits that are measured as normal, continuous variables employ linear regression 
models. Allele correlations between the SNP and the trait use Pearson’s r, which ranges from -1 
to 1; the higher the absolute value of the number, the greater the association. If, say, the A allele 
in the previous example is significantly more common among SCZ patients than the G allele, we 
can say that the SNP is linked to SCZ and that A is the risk allele.  
An important procedure in GWAS is the control of population stratification. Population 
stratification refers to the presence of different allele frequencies in ancestry groups that arises 
through selection-neutral processes like genetic drift in geographically distant populations 
(Novembre et al., 2008). Spurious associations can be found when ancestry-stratified alleles that 
have code for non-behavioral traits (e.g. skin, eye color, height) tag disparities between ancestry 
groups that are the result of purely social processes. For example, a GWAS on income and 
educational attainment in the United States would identify SNPs causing white skin as 
significant predictors if ancestry was not accounted for. 
 
The Basic Template of a GWAS: 
1. Genotype hundreds of thousands or millions of SNPs in tens of thousands of unrelated 
individuals. 
2. Perform quality control on the calls the SNP arrays provide to ensure accuracy. 
3. Impute millions of SNPs based on the patterns observed in the sequenced SNPs. 
4. Record how many of each allele each person has at each SNP. Since SNPs are 
predominantly bi-allelic (having only 2 common alleles), these will either be 0 for 
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individuals who did not inherit the “counted” allele of either parent, 1 for those that 
received one copy from a parent, and 2 for those that received a copy of the counted 
allele from both parents.  
5. Perform a regression analysis in which these allele counts are correlated with the trait of 
interest and important covariates like age and sex are controlled for. The most important 
covariate to control for is ancestry as measured by genotyping to avoid confounding 
population stratification.  
6. Identify SNPs associated with the outcome that are statistically significant after a 
Bonferroni multiple testing correction for 1 million tests at p = 5 ×10-8. 
 
Constrained by minute effect sizes and a severe multiple testing correction, extremely large 
samples are a necessity. After the aforementioned GIANT Consortium, closing the gap in the 
prediction of human height required an additional 2,593 SNPs and around 550,000 more people 
(Yengo et al., 2018). Given that GWAS is currently restricted to SNPs and no other form of 
mutation such as copy number variants (CNVs), this level of prediction is nonetheless 
impressive. Sample size is not the only road to statistical power, however. 
Current Study 
Largely because common variant effects are so small, many GWAS researchers combine 
effects across them using poly-genic risk scores, or GRSs (International Schizophrenia 
Consortium, 2009). For each SNP, the number of risk alleles (0 homozygous non-risk, 1 
heterozygous, 2 homozygous risk) an individual has is multiplied by the regression weight found 
in a previous “training” sample, and the resulting values for all of the SNPs are then summed 




(𝑆𝑁𝑃1𝑚𝑖𝑛𝑜𝑟 𝑎𝑙𝑙𝑒𝑙𝑒𝑠, 𝑖. 𝑒. 0/1/2 ∗ 𝛽1) + (𝑆𝑁𝑃2𝑚𝑖𝑛𝑜𝑟 𝑎𝑙𝑙𝑒𝑙𝑒𝑠 ∗ 𝛽2) + … + (𝑆𝑁𝑃𝑖𝑚𝑖𝑛𝑜𝑟 𝑎𝑙𝑙𝑒𝑙𝑒𝑠 ∗ 𝛽𝑖) (1) 
 
For example, a SNP with a weight of 0.3 would have a value of 2 × 0.3 = 0.6 for 
homozygotes of the risk allele, 1 × 0.3 = 0.3 for heterozygotes, and 0 × 0.3 = 0 for homozygotes 
of the non-risk allele. Two SNPs with identical combinations of allele number & weight would 
sum to 1.2, 0.6, and 0, respectively. Therefore, the more risk alleles an individual has across 
SNPs and the greater the effect of those alleles, the more likely it is that the person will score 
highly on the trait at hand.  
By combining the effects of candidate genes in a GRS, we can possibly detect effects 
sizes below those estimated by the extant candidate gene literature. Candidate genes may in fact 
be predictive of psychopathology but less so than previously believed.  
We applied the GRS method to 121 candidate “gene” SNPs (listed in Appendix) to predict 
psychopathology in the Gene, Environment, Mood study (Snyder, Young, & Hankin, 2017). 
Weights for the GRSs were obtained from GWASs on neuroticism, anxiety, and risk-taking 





CHAPTER 2: METHOD 
Training Sample 
Scoring weights were obtained from Churchhouse & Neale (2017) who conducted a 10.8 
million SNP GWASs on data from the UK Biobank. The UK Biobank is a public repository of 
medical and genetic data on a representative sample of 500,000 men and women aged 40-69 
from the UK. After they implemented quality control measures, data from 337,199 UK Biobank 
participants remained for their study (see Table 1 for trait-specific sample sizes). Three measures 
of psychopathology - neuroticism, worrying, and risk-taking - had three corresponding factor 
scores in GEM: general psychopathology, internalizing, and externalizing, respectively. In the 
bifactor model of psychopathology created by Caspi and colleagues (2014) that Snyder and 
colleagues (2017) used in the GEM testing sample, neuroticism no longer correlated with 
internalizing once the general psychopathology “p-factor” is accounted for, but anxiety does. 
Therefore, we used the worrying/anxious feelings GWAS for the internalizing factor. 
Regressions on all nine combinations of UKB traits and GEM factor scores were conducted for 
thoroughness, however. Height was incorporated as a negative control. 
 Table 1  
Sample Sizes Available for Each Trait out of Combined Total 
UKB Measure Sample Size Corresponding GEM Factor 
Neuroticism 274,108 P-factor 
Worrying/Anxious feelings 328,717 Internalizing 
Risk-taking 325,821 Externalizing 
Standing height 336,474 Negative Control 
 
Target Sample 
The target sample consisted of female (55.5%) and male adolescents aged 9-19 from the 
Gene, Environment Mood longitudinal study (Snyder et al., 2017). To limit multiple testing 
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liability, we restricted testing to the factor scores estimated in the GEM sample at Time 2, in 
consideration of consistent evidence of heritability of psychopathology increasing with age 
during adolescence (Bergen, Gardner, & Kendler, 2007) and evidence of homotypic continuity 
increasing with age for the internalizing factor within this sample (Snyder et al. 2017). On 
average, participants were 13.58 years old (SD = 2.37, range = 9.3–17.5) at T1 and 15.07 years 
old (SD = 2.36, range = 10.7–19.1) at T2.  
Data on 121 SNPs from 343 participants were included in the final analysis. From the 
original sample of 571 participants, 228 participants were removed for missing genotypes on 
more than 12 SNPs (~10%). 23 SNPs were dropped from the original 144 SNPs. 7 were 
unavailable in our training sample, and 5 had a high degree of missingness (>40% of genotypes). 
11 with ambiguous strands (i.e. A\T, T\A, C\G, G\C) were dropped for having minor allele 
frequencies between .35 and .50, which made them impossible to confidently verify using the 
1000 Genome estimates. Psychopathology in the GEM sample consisted of factor scores for 
general psychopathology (the “p-factor”; Caspi et al., 2014), internalizing, and externalizing in 
GEM (see Snyder et al., 2017 for details on their p-factor model). 
 
Polygenic Risk Scores and Statistical Analyses 
GRSs for each participant were calculated by multiplying the number of risk alleles per SNP 
(0,1,2) with the corresponding UKB regression coefficient, summed over all SNPs. No p-value 
threshold was used for SNP inclusion in the scores such that all 121 SNPs contributed to the 
GRSs regardless of their p-values in the UKB.  
Where βT is the association between a UKB phenotype GRS (neuroticism, worry, or risk 
taking) and its target phenotype (p-factor, internalizing, or externalizing, respectively); βNT is the 
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association(s) between a GRS and any of its non-target phenotypes; and β0 is the association(s) 
between a negative control GRS for height and any of the PIE phenotypes: 
• If βT > 0, aggregate genetic risk from the set of included candidate genes predicts the 
target phenotype. 
• If βNT ≠ 0, then the genetic risk is not specific to the target phenotype. 
• If β0 ≠ 0, the negative control (height) has failed, implying that estimates are biased (e.g. 
by unmeasured population stratification). 
 
We regressed each of the three PIE factors on each GRS, including age, gender, and dummy-
coded participant race/ethnicity as covariates: 
{𝑃, 𝐼, 𝐸} =  𝑏𝑖  𝐺𝑅𝑆𝑖 +   𝑏𝑎𝑔𝑒𝑎𝑔𝑒 +  𝑏𝑔𝑒𝑛𝑑𝑒𝑟𝑔𝑒𝑛𝑑𝑒𝑟 +  𝑏𝑟𝑎𝑐𝑒𝑟𝑎𝑐𝑒 +  𝑒𝑖𝑖 (2) 
 
Significance of the association between each of the GRSi and the p-factor, internalizing, 
and externalizing scores was evaluated by significance of the bi term. Multiple testing correction 
took into account the likely intercorrelation among behavioral GRSs. That is, it was understood 
that the prediction weights were likely not independent, and therefore that the effective number 
of independent tests would be lower than nine, the number of GRSs tested. We applied as a 
correction (Nyholt, 2014) method of accounting for non-independence of multiple tests: 
             
ɑ =  0.05 ÷ [ ( 1 + ( 𝑀𝐷𝑉  −  1 ) ( 1 − (
𝑉𝑎𝑟(ƛ𝐷𝑉)
𝑀𝐷𝑉






Where MDV is the number of dependent variables (here, the p-factor, internalizing, and 
externalizing); MIV is the number of target (i.e. non-control) GRSs used as independent variables 
(here, neuroticism, worry, and risk taking); Var(ƛDV) and Var(ƛIV) are the variances for the 
eigenvalues obtained from a correlation matrix of the dependent or independent variables, 
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respectively. For example, if the variables are entirely independent, then Var(ƛ) = 0 and ɑ = 0.05 
÷ (3 × 3) = 0.0056; if the PIE factors are entirely independent and the GRSs are perfectly 





CHAPTER 3: RESULTS 
Primary Analyses 
 
Figure 2. Comparison of the four GRSs’ prediction of psychopathology in GEM. 
 
None of the GRSs reached statistical significance before or after multiple test correction 
in any of the models (all p > 0.05). Gender was a significant predictor in all internalizing (all p < 
1.46 × 10-5) and externalizing (all p < .0267) models, and age was a significant predictor in all p-
factor models (all p < 4.04 × 10-5). Substantial correlation was observed between the 
neuroticism, worry, risk-taking, and height GRSs (Table 2), which accounts for the remarkable 
similarity of the regression results across all models. Oddly, both neuroticism and worry were 





Table 2  
Correlation matrix for all variables across all 12 models (incl. control)  
Variable 1 2 3 4 5 6 7 8 
1. GEM P-factor —        
2. GEM Internalizing 0.12 —       
3. GEM Externalizing 0.33 -0.34 —      
4. Neuroticism GRS -0.03 -0.07 0.01 —     
5. Worry GRS -0.04 -0.05 0.00 0.87 —    
6. Risk-taking GRS -0.10 -0.02 -0.02 0.42 0.34 —   
7. Height GRS -0.05 0.02 0.03 -0.62 -0.67 -0.42 —  
8. Age 0.23 -0.04 0.04 0.03 -0.02 -0.06 0.09 — 
 
Secondary Analysis: Performance of Candidate SNPs in the UKB 
Though we did not find evidence for the GRSs having a significant effect on 
psychopathology, the GEM sample may have been underpowered to detect the true effects of the 
SNPs, as their magnitudes may be more typical of GWAS. To determine the prediction strength 




Figure 3. QQ plots of -log10 p-values for 10 million SNPs available in the UKB data. P-
values for the candidate SNPs are in red.  
Five candidate SNPs reached the genome-wide significance threshold (p < 5× 10-8) in the 
UKB GWAS on neuroticism: rs878886, rs1876828, rs242924, rs110402, rs2715148 (Appendix). 
Of these, rs878886 and rs1876828 were also significant predictors of worrying/anxiety and 
height. Compared to the best performing candidate SNP, p-values were lower for 1,809 SNPs in 





CHAPTER 4: DISCUSSION 
None of the genetic risk scores were significant predictors of psychopathology in the 
GEM sample. With 343 participants, we had 80% power to detect Pearson correlations of 0.155 
magnitude after multiple testing correction. The combined effect of 121 candidate genes was 
insufficient, only amounting to a maximum of r = -.10 between the neuroticism GRS and 
internalizing. The candidate genes also showed poor performance in the larger UKB training 
samples, of which the smallest (N = 274,108) had 80% power to detect correlations of r = 0.012 
at the genome-wide significance level of 5 × 10-8. Only 5 candidate SNPs were genome-wide 
significant in the neuroticism GWAS, and they were surpassed by thousands of other SNPs. Two 
of the five were also significant predictors of height. This means that the 121 candidate genes we 
tested were not strong, much less uniquely strong, predictors of psychopathology.   
 As can be seen in Figure 2, substantial correlation between the candidate GRSs was 
observed. While intercorrelation among the psychopathology measures (neuroticism, worry, risk-
taking) might be expected, the strong correlation with height was surprising. This may indicate 
that the effect estimates are biased by unmeasured population stratification within the GEM 
sample. The population frequencies of candidate genes differ between ancestry groups that are 
inadequately labeled with self-reported race. Just like other candidate gene studies, we cannot 
test for the possibility of population stratification in our sample because of the absence of 
sufficient genome-wide data needed to estimate genetic ancestry (Novembre et al., 2008). 
 Alternately, the genetic contribution of these candidate genes to psychopathology may be 
pleiotropic (pleion “more” and tropos “way” in Greek), with some of these candidate SNPs in 
particular bearing wide-ranging effects on body size as well as mental health. The two SNPs 
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shared by the neuroticism, worry, and height GWASs as significant predictors - rs878886 and 
rs1876828 -  lie within the corticotropin-releasing hormone receptor 1 (CRHR1) gene. 
Corticotropin-releasing hormone (CRH) is a stress hormone of the HPA axis that is implicated in 
anxiety disorders, but CRH also affects appetite and metabolism (Laryea, Arnett, & Muglia, 
2012) which could in turn influence height.  
 Our results indicate that researchers should look elsewhere for strong genetic predictors 
of psychopathology. Our use of SNPs does not rule out the potential role of rare variants within 
these genes, but the common variants used previously in research should be regarded with 
caution. Future GWAS research should employ GWAS-sized samples to explore the possibility 
of weaker but useful effects than could be detected with our sample size. Ideally, these would be 
in studies as “well-phenotyped” as GEM in which thorough, validated measures are used and 
participants are followed over time. Such work would capitalize on the advantages smaller 
studies have over large consortia, providing the beneficial properties researchers sought from 
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APPENDIX: LIST OF THE 121 CANDIDATE GENE SNPs  
Table 3  
The 121 Candidate SNPs Analyzed and their Betas in the UKB 
 
rsid Allele Frequency Neuroticism Worry Risk-taking Height 
rs878886 G 10.69% 0.0949* 0.008* 0.0019 -0.013* 
rs1876828 T 60.36% 0.0949* 0.008* 0.0019 -0.013* 
rs242924 G 37.07% -0.0509* -0.0044 -0.0015 0.0047 
rs110402 G 37.30% -0.0508* -0.0043 -0.0014 0.0045 
rs7209436 C 33.60% -0.0498* -0.0043 -0.0013 0.0046 
rs2715148 A 31.58% 0.0475* 0.0043 0.0018 -0.0020 
rs1800497 A 54.30% 0.057* 0.0032 0.0023 0.0009 
rs13438494 T 28.50% 0.0461* 0.0045 0.0018 -0.0022 
rs2522833 C 41.48% 0.0458* 0.0042 0.0014 -0.0005 
rs6265 T 19.54% 0.0329 0.0060 -0.0057 0.0049 
rs4757138 A 24.62% -0.0282 -0.0028 0.0037 -0.0135* 
rs242939 C 5.88% 0.0517 0.0045 0.0008 -0.0128 
rs12884323 C 35.98% -0.0246 0.0004 -0.0013 0.0007 
rs5522 C 8.84% 0.0365 0.0027 0.0007 -0.0004 
rs35369693 C 69.07% -0.0435 -0.0005 -0.0007 0.0023 
rs33933482 A 58.48% -0.0317 -0.0005 -0.0006 0.0034 
rs265974 G 42.48% 0.0186 0.0015 0.0013 -0.0045 
rs2020934 A 37.06% -0.0166 -0.0009 0.0002 -0.0116* 
rs53576 A 35.01% -0.0176 -0.0004 0.0022 0.0007 
rs237897 A 27.75% -0.0163 -0.0009 0.0026 0.0003 
rs594242 C 12.73% 0.0189 0.0024 -0.0006 -0.0026 
rs1800796 C 10.70% -0.0369 -0.0036 0.0006 0.0094 
rs1824024 C 28.85% 0.0156 0.0016 -0.0019 -0.0015 
rs17110489 C 53.38% -0.0165 -0.0044 0.0004 -0.0015 
rs1959813 C 29.08% -0.0146 0.0007 -0.0026 0.0019 
rs17486278 C 47.60% 0.0153 0.0018 -0.0038 -0.0028 
rs904467 A 57.86% 0.0169 0.0012 0.0004 -0.0021 
rs4448731 C 39.73% -0.0142 -0.0007 -0.0020 0.0024 
rs3007105 T 39.46% 0.0143 -0.0007 0.0030 -0.0022 
rs10496417 A 25.52% 0.0143 -0.0002 -0.0009 -0.0025 
rs4792887 T 63.65% -0.0244 -0.0024 -0.0009 0.0142* 
rs16969968 A 52.74% 0.0146 0.0018 -0.0038 -0.0028 
rs4675690 T 38.51% -0.0136 -0.0033 0.0018 0.0005 
rs4583306 G 39.11% 0.0132 -0.0004 0.0006 0.0071 
rs7940188 C 4.51% -0.1839 -0.0275 -0.0110 0.0425 
rs3794808 C 37.33% 0.0129 -0.0003 0.0002 0.008* 
rs12291063 C 67.38% -0.1772 -0.0284 -0.0096 0.0432 
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Table 3  
The 121 Candidate SNPs Analyzed and their Betas in the UKB (cont.) 
 
rs2020936 G 16.20% 0.0159 0.0011 0.0020 0.0009 
rs3764352 C 24.48% 0.0152 0.0022 0.0009 0.0040 
rs165599 A 27.27% 0.0135 -0.0026 0.0040 0.0041 
rs4570625 T 51.95% -0.0151 -0.0042 -0.0007 0.0005 
rs3750344 C 59.91% 0.0164 0.0030 0.0020 -0.0010 
rs907094 G 24.55% 0.0149 0.0022 0.0009 0.0040 
rs12443955 G 20.21% 0.0127 -0.0005 -0.0002 0.0022 
rs6354 G 14.38% 0.0139 0.0011 0.0016 0.0010 
rs854560 T 49.85% -0.0114 -0.0009 -0.0017 -0.0008 
rs140700 T 65.90% -0.0189 -0.0013 -0.0021 -0.0006 
rs140701 T 36.81% 0.0110 -0.0006 0.0004 0.0074 
rs16965628 C 63.93% -0.0222 -0.0032 -0.0018 -0.0041 
rs1042173 C 36.17% 0.0104 0.0004 0.0000 0.0093* 
rs6869645 T 67.29% -0.0219 -0.0013 -0.0013 0.0031 
rs2061174 G 27.38% 0.0104 0.0003 -0.0019 -0.0024 
rs6314 A 65.32% -0.0169 0.0003 -0.0017 0.0039 
rs643627 C 49.62% 0.0106 0.0016 0.0000 0.0019 
rs28536160 C 56.29% 0.0251 0.0015 -0.0067 -0.0037 
rs7569963 A 52.18% 0.0099 0.0026 -0.0024 0.0035 
rs1801260 G 51.35% -0.0098 -0.0005 0.0011 0.0000 
rs11174811 A 63.60% -0.0121 -0.0043 0.0001 0.0018 
rs35608965 C 67.36% 0.0230 0.0015 -0.0064 -0.0039 
rs1800795 C 48.43% -0.0085 0.0000 0.0006 0.0059 
rs806368 C 55.55% -0.0102 0.0001 -0.0008 -0.0015 
rs4680 A 38.62% -0.0081 -0.0027 0.0024 0.0035 
rs6196 G 62.11% -0.0107 -0.0024 -0.0007 0.0074 
rs4633 T 37.97% -0.0081 -0.0026 0.0023 0.0033 
rs12635797 T 59.93% 0.0131 0.0028 -0.0007 0.0004 
rs279858 C 43.47% -0.0077 0.0018 -0.0055 -0.0041 
rs2230912 G 61.69% -0.0102 0.0004 0.0012 -0.0018 
rs279871 C 43.10% -0.0076 0.0018 -0.0054 -0.0041 
rs1587097 T 66.20% -0.0113 -0.0051 0.0009 0.0000 
rs578776 G 44.89% -0.0078 -0.0019 0.0039 0.0029 
rs7766029 C 38.32% -0.0067 -0.0020 0.0009 -0.0004 
rs2268493 C 55.66% -0.0071 0.0005 0.0024 -0.0020 
rs569207 T 50.89% -0.0074 -0.0026 0.0038 0.0018 
rs1799913 T 44.78% -0.0063 -0.0015 0.0020 0.0122* 
rs2267717 A 59.21% -0.0100 -0.0011 -0.0028 0.0077 
rs662 T 44.25% 0.0067 -0.0003 0.0007 -0.0023 




The 121 Candidate SNPs Analyzed and their Betas in the UKB (cont.) 
 
rs7933505 A 45.38% -0.0061 -0.0014 0.0020 0.0124* 
rs1562027 A 22.93% 0.0066 0.0020 -0.0005 0.0044 
rs1360780 T 22.31% 0.0064 0.0046 -0.0019 0.0006 
rs12273539 T 67.21% -0.0730 -0.0188 -0.0060 0.0331 
rs7594560 C 61.81% 0.0081 0.0005 0.0003 0.0003 
rs13355613 T 57.73% -0.0064 -0.0014 0.0004 0.0048 
rs737865 G 51.94% 0.0059 0.0004 -0.0017 -0.0028 
rs1801133 A 50.90% -0.0056 0.0018 0.0000 -0.0002 
rs3800373 C 22.31% 0.0056 0.0047 -0.0011 0.0022 
rs9470080 T 24.48% 0.0053 0.0048 -0.0028 0.0016 
rs1799971 G 60.95% 0.0074 0.0046 -0.0025 0.0029 
rs2270007 G 11.24% 0.0066 0.0006 0.0015 -0.0074 
rs40184 T 39.87% -0.0048 -0.0008 0.0003 0.0019 
rs9380526 C 23.07% 0.0050 0.0048 -0.0029 0.0015 
rs9534511 T 32.54% 0.0045 0.0008 -0.0011 -0.0026 
rs2709376 T 4.60% 0.0129 0.0052 -0.0014 0.0040 
rs2395634 A 22.67% 0.0047 0.0043 -0.0017 0.0010 
rs6311 T 39.24% 0.0043 0.0010 -0.0009 -0.0022 
rs2304672 C 6.04% 0.0077 -0.0035 0.0011 0.0023 
rs9296158 A 23.47% 0.0044 0.0044 -0.0017 0.0010 
rs497068 G 29.51% 0.0040 -0.0022 0.0050 0.0043 
rs6198 C 61.14% 0.0054 0.0010 -0.0011 0.0102 
rs6190 T 70.81% 0.0116 0.0052 -0.0057 0.0057 
rs16147 T 32.91% -0.0037 -0.0003 0.0007 0.0054 
rs2963238 G 31.50% -0.0038 0.0008 -0.0006 -0.0059 
rs1819741 C 49.41% -0.0040 -0.0008 -0.0016 0.0009 
rs7997012 A 23.79% -0.0034 -0.0009 0.0002 -0.0029 
rs4606 G 48.81% -0.0038 -0.0008 -0.0016 0.0008 
rs27048 T 42.67% -0.0034 0.0010 0.0015 0.0000 
rs4234955 G 24.48% -0.0036 0.0000 0.0008 0.0000 
rs4251417 T 66.49% 0.0052 0.0014 0.0020 -0.0132* 
rs429358 C 62.61% -0.0034 0.0033 -0.0003 0.0024 
rs10482672 A 60.55% 0.0036 0.0003 -0.0017 -0.0049 
rs324389 T 47.90% 0.0024 -0.0001 -0.0026 -0.0017 
rs548583 A 29.79% 0.0021 -0.0023 0.0053 0.0038 
rs1013940 G 67.66% -0.0034 -0.0009 -0.0006 0.0013 
rs2254298 A 15.02% -0.0026 0.0012 0.0006 -0.0025 
rs1490453 A 58.35% -0.0016 -0.0009 -0.0013 0.0006 
rs2253206 G 34.87% -0.0011 -0.0008 0.0022 -0.0041 
rs6330 A 44.86% 0.0007 0.0012 -0.0005 0.0073 
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rs33976516 G 67.26% -0.0020 -0.0002 -0.0064 -0.0018 
rs9534496 C 13.20% 0.0007 -0.0006 -0.0005 -0.0009 
rs2020942 T 49.85% 0.0005 0.0015 0.0008 -0.0061 
rs1611115 T 16.27% -0.0002 -0.0007 -0.0004 0.0005 
* denotes significance at the p < 5 × 10-8 genome-wide significance level 
 
